SIRT1-overexpression did not influence the anticancer effects of an every-other-day fasting regimen (a variation of CR) in a p53-deficient mouse model of cancer, suggesting that SIRT1 may have a limited role in the effects of CR on cancer[89]. Here, TP53 is linked to cancer.